SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000318306-14-000015
Filing Date
2014-04-15
Accepted
2014-04-15 17:06:18
Documents
1
Period of Report
2014-04-15
Effectiveness Date
2014-04-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT proxy041514.htm DEF 14A 453691
  Complete submission text file 0000318306-14-000015.txt   454934
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 14765676
SIC: 2834 Pharmaceutical Preparations